Antibody–Drug Conjugates for Cancer Therapy

Mostrar otras versiones (1)

Antibody–drug conjugates (ADCs) are novel drugs that exploit the specificity of a monoclonal antibody (mAb) to reach target antigens expressed on cancer cells for the delivery of a potent cytotoxic payload. ADCs provide a unique opportunity to deliver drugs to tumor cells while minimizing toxicity t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafeez, Umbreen, Parakh, Sagun, Gan, Hui K., Scott, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587605/
https://www.ncbi.nlm.nih.gov/pubmed/33081383
http://dx.doi.org/10.3390/molecules25204764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587605/
https://www.ncbi.nlm.nih.gov/pubmed/33081383
http://dx.doi.org/10.3390/molecules25204764

Ejemplares similares